AI-Powered Drug Innovation: From Discovery to Development

AI-Powered Drug Innovation: From Discovery to Development The traditional journey of drug discovery and development is long, expensive, and fraught with uncertainty. Today, artificial intelligence is transforming this paradigm, offering the potential to significantly compress timelines across the entire spectrum, from initial target identification through preclinical studies and clinical trials. By enabling sophisticated modeling of biological systems and patient responses with exceptional precision, AI is not only accelerating the identification of promising drug candidates but also optimizing their development pathways. This session will explore what breakthroughs are already reshaping the field—and which are just around the corner. What are the strategic and regulatory hurdles to integrating these tools into an industry built on rigorous validation? And how can we harness the full promise of AI while safeguarding the trust, safety, and ethics that underpin medical innovation?